CLINICAL_TRIALS
research
· 2025-01-23
Clinical Trial Update: CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes
Summary
This clinical trial evaluates whether CENP-V protein levels in human oocytes can serve as a diagnostic marker of damage from aging or the vitrification/thawing …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vida Recoletas Sevilla | Conditions: Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes, Advance Maternal Age | Status: RECRUITING